Medicine & Life Sciences
Japan
100%
Therapeutics
69%
Registries
63%
Transcatheter Aortic Valve Replacement
59%
Rheumatoid Arthritis
57%
Heart Failure
56%
Cardiac Myocytes
52%
Hematopoietic Stem Cell Transplantation
48%
Kidney
47%
Percutaneous Coronary Intervention
45%
Ulcerative Colitis
43%
Myasthenia Gravis
42%
Lung
40%
Safety
34%
Induced Pluripotent Stem Cells
34%
Atrial Fibrillation
34%
Serum
32%
Mortality
32%
Type 2 Diabetes Mellitus
32%
Confidence Intervals
31%
T-Lymphocytes
31%
Coronavirus
29%
Heart
27%
Helicobacter pylori
27%
Inflammation
27%
tocilizumab
27%
Antibodies
27%
Crohn Disease
27%
Mutation
26%
Genes
26%
Blood Pressure
26%
Pulmonary Hypertension
25%
Odds Ratio
24%
Neoplasms
24%
Incidence
23%
Inflammatory Bowel Diseases
23%
Graft vs Host Disease
23%
Survival
23%
Glucose
22%
Hyperaldosteronism
22%
Myositis
22%
Hemorrhage
22%
Chronic Renal Insufficiency
22%
Transplants
22%
Transplantation
22%
Hypertension
22%
Cohort Studies
21%
Chronic Obstructive Pulmonary Disease
21%
Renin
21%
Macrophages
21%
Cell Transplantation
21%
Recurrence
20%
Cardiovascular Diseases
20%
Myocardial Infarction
20%
Phenotype
19%
Cytokines
19%
Pulmonary Arterial Hypertension
19%
Multicenter Studies
19%
Bone Marrow Transplantation
19%
Colitis
18%
Liver
18%
Retrospective Studies
18%
Autoantibodies
18%
Tomography
18%
Allogeneic Cells
18%
Endoscopic Mucosal Resection
18%
Interstitial Lung Diseases
18%
Methotrexate
18%
Non-Small Cell Lung Carcinoma
18%
Stem Cells
17%
Obesity
17%
Muscular Diseases
17%
Quality of Life
17%
Catheter Ablation
17%
Biomarkers
17%
Mycobacterium avium Complex
16%
Stroke
16%
Pluripotent Stem Cells
16%
Aldosterone
16%
Population
16%
Stomach
16%
Pharmaceutical Preparations
15%
Interleukin-6
15%
Bone Marrow
15%
Acute Coronary Syndrome
15%
Interferons
15%
Balloon Angioplasty
14%
Organoids
14%
Arterioles
14%
Anti-Idiotypic Antibodies
14%
Lung Neoplasms
14%
Proteins
14%
Infections
14%
Fibrosis
14%
Lung Diseases
14%
Asthma
14%
Tissue Donors
14%
Migraine Disorders
14%
Elderly
13%
Angiotensin II
13%